Post-marketing authorisation: Regulatory and procedural guidance

  • Email
  • Help

See the full regulatory and procedural guidance index

Important note on document formats: All Microsoft Office documents submitted to the European Medicines Agency must be in a format compatible with MS Office 2003. Office 2007 and Office 2010 formats cannot currently be accepted.

Back to top

Document(s) Language Status First published Last updated Effective Date
Questions and Answers on variations to an existing pharmacovigilance system as described in the DDPS (English only) adopted 02/03/2011    
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure (English only)   01/07/2009 26/04/2012  
European Medicines Agency procedural advice for users of the centralised procedure for generic/hybrid applications (English only)   02/07/2008 26/01/2012  
Procedural advice to CHMP members (English only) adopted 06/08/2008    
Procedural advice on the re-examination of CHMP opinions (English only) draft: consultation closed 12/02/2009    
Guidance for the provision of data (excluding paediatric data) not yet submitted to the EMEA (English only) adopted 13/09/2005